IBP Stock +106.23% Since Nov ’07 Pick IBP Stock +106.23% Since Nov ’07 Pick Unlock Top Buy Picks

Range Low Price High Price Comment
30 days $5.39 $7.70 Monday, 15th Apr 2024 FATE stock ended at $5.64. This is 2.25% less than the trading day before Friday, 12th Apr 2024. During the day the stock fluctuated 10.39% from a day low at $5.39 to a day high of $5.95.
90 days $4.10 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
2024-02-01 $6.24 $6.89 $6.04 $6.76 6 184 799
2024-01-31 $5.52 $6.64 $5.47 $6.16 6 694 150
2024-01-30 $5.64 $5.77 $5.42 $5.58 2 777 392
2024-01-29 $4.56 $5.95 $4.43 $5.72 7 282 103
2024-01-26 $4.63 $4.69 $4.44 $4.56 1 397 337
2024-01-25 $4.66 $4.80 $4.40 $4.56 1 586 435
2024-01-24 $4.97 $4.98 $4.59 $4.61 2 651 389
2024-01-23 $4.80 $4.97 $4.72 $4.83 2 229 365
2024-01-22 $4.62 $4.98 $4.56 $4.72 3 118 152
2024-01-19 $4.40 $4.63 $4.10 $4.53 2 805 882
2024-01-18 $4.43 $4.58 $4.18 $4.33 2 663 083
2024-01-17 $4.31 $4.69 $4.24 $4.40 2 157 765
2024-01-16 $4.42 $4.74 $4.41 $4.51 2 377 502
2024-01-12 $4.57 $4.75 $4.37 $4.55 3 222 640
2024-01-11 $4.49 $4.65 $4.30 $4.45 2 525 706
2024-01-10 $4.42 $4.63 $4.27 $4.57 3 248 650
2024-01-09 $4.05 $4.53 $3.98 $4.41 3 616 289
2024-01-08 $3.80 $4.29 $3.59 $4.12 3 457 500
2024-01-05 $3.76 $3.96 $3.62 $3.77 1 126 759
2024-01-04 $3.55 $3.94 $3.50 $3.84 2 131 506
2024-01-03 $3.58 $3.66 $3.46 $3.54 2 701 106
2024-01-02 $3.66 $4.10 $3.56 $3.69 1 705 562
2023-12-29 $4.09 $4.11 $3.72 $3.74 1 650 440
2023-12-28 $3.65 $4.13 $3.65 $3.94 1 683 229
2023-12-27 $3.78 $3.94 $3.57 $3.66 2 034 882
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT